CFDE Data Portal | Search RPS3AP24

	Label	Description
	RPS3AP24 Gene (Entity type)	ENSG00000217684 - RPS3A pseudogene 24
	GSE119369 H10 inhibition 1 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE142357 HDAC3 inhibition 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE224004 GSE224005 CHD4 EWS-FLI1 knockdown 0 v 8 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE178267 vemurafenib 2 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE228357 OGA knockdown 2 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GTEx Testis 20-29 vs 60-69 Up Gene Set (Entity type)	A Gene Set from GTEx
	PSKH2 IDG kinase ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG
	ADGRG4 IDG GPCR ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG
	GSE99503 GSK3 TUNAR inhibition B cell 0 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS

RPS3AP24

ENSG00000217684 - RPS3A pseudogene 24

GSE119369 H10 inhibition 1 v 6 human dn

A Gene Set from LINCS

GSE142357 HDAC3 inhibition 1 v 3 human up

A Gene Set from LINCS

GSE224004 GSE224005 CHD4 EWS-FLI1 knockdown 0 v 8 human up

A Gene Set from LINCS

GSE178267 vemurafenib 2 v 0 human up

A Gene Set from LINCS

GSE228357 OGA knockdown 2 v 0 human dn

A Gene Set from LINCS

GTEx Testis 20-29 vs 60-69 Up

A Gene Set from GTEx

PSKH2 IDG kinase ARCHS4 coexpression

A Gene Set from IDG

ADGRG4 IDG GPCR ARCHS4 coexpression

A Gene Set from IDG

GSE99503 GSK3 TUNAR inhibition B cell 0 v 3 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.